The rationale for using hydroxycarbamide in the treatment of sickle cell disease

Lignende værker

• The rationale for using hydroxycarbamide in the treatment of sickle cell disease” (Haematologica 2011;96:488–491). Reply
  af: Pollack, Simeon
  Udgivet: (2011)
• Hydroxyurea (hydroxycarbamide) for sickle cell disease
  af: Nevitt, Sarah J, et al.
  Udgivet: (2017)
• Hydroxycarbamide and White Matter Integrity in Paediatric Sickle Cell Disease
  af: Lance, Eboni I., et al.
  Udgivet: (2019)
• Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease
  af: Wiles, NM, et al.
  Udgivet: (2009)
• Oscillatory haematopoiesis in adults with sickle cell disease treated with hydroxycarbamide
  af: Baird, John H., et al.
  Udgivet: (2014)